+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transcriptomics Technologies Market Report: Trends, Forecast and Competitive Analysis to 2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2023
  • Region: Global
  • Lucintel
  • ID: 5910071

Transcriptomics Technologies Trends and Forecast

The future of the global transcriptomics technologies market looks promising with opportunities in the drug discovery and diagnostics & disease profiling markets. The global transcriptomics technologies market is expected to reach an estimated $11.5 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing adoption of personalized medicines, increasing prevalence of chronic disorders, and on-going research and development in transciptomics.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Transcriptomics Technologies by Segment

The study includes a forecast for the global transcriptomics technologies by type, technology, application, and region.

Transcriptomics Technologies Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software
  • Services

Transcriptomics Technologies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Microarrays
  • q PCR
  • Sequencing Technology

Transcriptomics Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

Transcriptomics Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transcriptomics Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transcriptomics technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcriptomics technologies companies profiled in this report include-
  • Agilent Technologies
  • Sequentia Biotech Sl
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation
  • Genxpro
  • Merck
  • Bio-Rad Laboratories

Transcriptomics Technologies Market Insights

The publisher forecasts that consumables will remain the larger segment over the forecast period.
Within this market, drug discovery is expected to remain the largest segment due to growing demand for new drugs to treat chronic diseases and rising application of transcriptomics technologies in drug discovery research.
North America will remain the largest region during the forecast period due to rising R&D investments by pharmaceutical and biotechnology companies in the region.

Features of the Global Transcriptomics Technologies Market

  • Market Size Estimates: Transcriptomics technologies market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Transcriptomics technologies market size by type, technology, application, and region in terms of value ($B).
  • Regional Analysis: Transcriptomics technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, technologies, applications, and regions for the transcriptomics technologies market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcriptomics technologies market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the transcriptomics technologies market size?
Answer: The global transcriptomics technologies market is expected to reach an estimated $11.5 billion by 2030.

Q.2 What is the growth forecast for transcriptomics technologies market?
Answer: The global transcriptomics technologies market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcriptomics technologies market?
Answer: The major drivers for this market are growing adoption of personalized medicines, increasing prevalence of chronic disorders, and on-going research and development in transciptomics.

Q4. What are the major segments for transcriptomics technologies market?
Answer: The future of the transcriptomics technologies market looks promising with opportunities in the drug discovery and diagnostics & disease profiling markets.

Q5. Who are the key transcriptomics technologies market companies?

Answer: Some of the key transcriptomics technologies companies are as follows:

  • Agilent Technologies
  • Sequentia Biotech Sl
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation
  • Genxpro
  • Merck
  • Bio-Rad Laboratories
Q6. Which transcriptomics technologies market segment will be the largest in future?
Answer: The publisher forecasts that consumables will remain the larger segment over the forecast period.
.

Q7. In transcriptomics technologies market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region during the forecast period due to rising R&D investments by pharmaceutical and biotechnology companies in the region.

Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the transcriptomics technologies market by type (consumables, instruments, software, and services), technology (microarrays, q PCR, and sequencing technology), application (drug discovery, diagnostics & disease profiling, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
2. Global Transcriptomics Technologies Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Transcriptomics Technologies Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Transcriptomics Technologies Market by Type
3.3.1: Consumables
3.3.2: Instruments
3.3.3: Software
3.3.4: Services
3.4: Global Transcriptomics Technologies Market by Technology
3.4.1: Microarrays
3.4.2: q PCR
3.4.3: Sequencing Technology
3.5: Global Transcriptomics Technologies Market by Application
3.5.1: Drug Discovery
3.5.2: Diagnostics & Disease Profiling
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Transcriptomics Technologies Market by Region
4.2: North American Transcriptomics Technologies Market
4.2.2: North American Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.3: European Transcriptomics Technologies Market
4.3.1: European Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
4.3.2: European Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.4: APAC Transcriptomics Technologies Market
4.4.1: APAC Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
4.4.2: APAC Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.5: ROW Transcriptomics Technologies Market
4.5.1: ROW Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
4.5.2: ROW Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Transcriptomics Technologies Market by Type
6.1.2: Growth Opportunities for the Global Transcriptomics Technologies Market by Technology
6.1.3: Growth Opportunities for the Global Transcriptomics Technologies Market by Application
6.1.4: Growth Opportunities for the Global Transcriptomics Technologies Market by Region
6.2: Emerging Trends in the Global Transcriptomics Technologies Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Transcriptomics Technologies Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcriptomics Technologies Market
7. Company Profiles of Leading Players
7.1: Agilent Technologies
7.2: Sequentia Biotech SL
7.3: Affymetrix
7.4: LC Sciences
7.5: CD Genomics
7.6: Thermo Fisher Scientific
7.7: Life Technologies Corporation
7.8: GenXPro
7.9: Merck
7.10: Bio-Rad Laboratories

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies
  • Sequentia Biotech Sl
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation

Methodology

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...